Department of Medicine III, Division of Rheumatology, Medical University Vienna, , Vienna, Austria.
Ann Rheum Dis. 2014 Jan;73(1):114-23. doi: 10.1136/annrheumdis-2013-203284. Epub 2013 Apr 16.
The 2010 ACR/EULAR classification criteria for rheumatoid arthritis (RA) were developed to improve the identification of individuals for studies of RA. We aimed to summarise the performance of the criteria based on the published literature.
We performed a systematic literature search to identify all studies investigating the 2010 criteria and reporting data allowing to calculate sensitivity (SENS), specificity (SPEC), and positive and negative predictive values. Where possible, meta-analysis was performed.
Seventeen full articles (total 6816 patients) and 17 meeting abstracts (total 4004 patients) fulfilled the inclusion criteria. Pooled sensitivity and specificity for RA (defined by different reference standards) were 0.82 (95% CI 0.79-0.84) and 0.61 (0.59-0.64). Results were comparable for different reference standards: for initiation of methotrexate pooled sensitivity was 0.85 (0.83-0.86) and specificity was 0.52 (0.49-0.54); for initiation of any disease modifying antirheumatic drug they were 0.80 (0.79-0.82) and 0.65 (0.61-0.68), respectively; and for expert opinion 0.88 (0.86-0.90) and 0.48 (0.35-0.52). No differences were observed for use of different types of joint counts. Eight studies and five meeting abstracts directly compared 1987 and 2010 criteria using different reference standards within different target populations showing higher overall sensitivity (+0.11 compared with 1987 criteria) at the cost of lower overall specificity (-0.04).
Two years after their publication, the 2010 ACR/EULAR criteria have been widely tested in the community. They are sensitive to detect cases of RA among various target populations, independent of how the latter is referenced.
2010 年 ACR/EULAR 类风湿关节炎(RA)分类标准旨在提高 RA 研究人群的识别能力。本研究旨在根据已发表文献总结该标准的性能。
我们进行了系统文献检索,以确定所有研究 2010 标准并报告数据允许计算敏感性(SENS)、特异性(SPEC)以及阳性和阴性预测值的研究。在可能的情况下,进行了荟萃分析。
17 篇全文文章(共 6816 例患者)和 17 篇会议摘要(共 4004 例患者)符合纳入标准。不同参考标准定义的 RA 的汇总敏感性和特异性分别为 0.82(95%CI 0.79-0.84)和 0.61(0.59-0.64)。不同参考标准的结果相当:甲氨蝶呤起始治疗的汇总敏感性为 0.85(0.83-0.86)和特异性为 0.52(0.49-0.54);任何疾病修饰抗风湿药物起始治疗的敏感性分别为 0.80(0.79-0.82)和特异性为 0.65(0.61-0.68);专家意见的敏感性为 0.88(0.86-0.90)和特异性为 0.48(0.35-0.52)。使用不同类型的关节计数没有观察到差异。8 项研究和 5 项会议摘要直接比较了使用不同参考标准在不同目标人群中 1987 年和 2010 年标准,结果显示总体敏感性(与 1987 年标准相比增加 0.11)更高,而特异性(总体降低 0.04)更低。
在发布后的两年内,2010 年 ACR/EULAR 标准已在社区中得到广泛验证。它们对各种目标人群中的 RA 病例具有较高的敏感性,而与人群如何参考无关。